Vinge advises Wilson Therapeutics in connection with the offer from Alexion
Alexion has announced a public cash offer to the shareholders of Wilson Therapeutics AB.
The offer values Wilson Therapeutics at approximately SEK 6,564 million.
Vinge advises Wilson Therapeutics in connection with the offer. Vinge’s team is primarily composed of Erik Sjöman, Christian Lindhé, Astrid Karlsson and Philip Åberg.